News and media

The groundbreaking ASPiRATION project is the first genomic profiling research project for patients with lung cancer in Australia. Each patient will have their particular disease individually tested, helping doctors to choose the right treatment for the right patient at the right time.

We’re looking for people with expertise in relevant clinical or scientific fields or health consumer issues to help ensure the safety of Australia’s medicines and medical products.

Australia’s medical device regulator has announced it is proposing to take strong and decisive action to suspend or cancel and recall certain textured breast implants from the Australian market, following a review of apparent links to rare forms of cancer.

Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).

Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).

Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.

Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.